De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J Neuropathol Exp Neurol 1999; 58: 174-187.
Lagord C, Berry M, Logan A. Expression of TGF-β2 but not TGF-β1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 2002; 20: 69-82.
Peress NS, Perillo E. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol 1995; 54: 802-811.
McTigue DM, Popovich PG, Morgan TE, Stokes BT. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp Neurol 2000; 163: 220-230.
Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 2004; 29: 966-971.
Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 1995; 45: 1561-1569.
Rogister B, Delree P, Leprince P, Martin D, Sadzot C, Malgrange B et al. Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 1993; 34: 32-43.
Unsicker K, Krieglstein K. TGF-betas and their roles in the regulation of neuron survival. Adv Exp Med Biol 2002; 513: 353-374.
Flanders KC, Ludecke G, Engels S, Cissel DS, Roberts AB, Kondaiah P et al. Localization and actions of transforming growth factor-betas in the embryonic nervous system. Development 1991; 113: 183-191.
Mangasser-Stephan K, Gressner AM. Molecular and functional aspects of latent transforming growth factor-beta binding protein: just a masking protein? Cell Tissue Res 1999; 297: 363-370.
Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int 1992; 41: 557-559.
Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998; 152: 74-87.
Bunge RP, Puckett WR, Hiester ED. Observations on the pathology of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv Neurol 1997; 72: 305-315.
Logan A, Green J, Hunter A, Jackson R, Berry M. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci 1999; 11: 2367-2374.
Moon LD, Fawcett JW. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGF beta1 and beta2. Eur J Neurosci 2001; 14: 1667-1677.
Buss A, Brook GA, Kakulas B, Martin D, Franzen R, Schoenen J et al. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 2004; 127: 34-44.